Industrial conglomerate 3M Company is partnering with the Massachusetts Institute of Technology to develop a cheaper, quicker COVID-19 test.
Right now, test results can take anywhere from a few hours to a week. Quest Diagnostics, for instance, said the average turnaround time at its labs is currently seven days.
3M's new test would function more like a pregnancy strip, a rapid paper-based test that could be mass-produced and quickly distributed at the point of care.
"In terms of patient experience, what we're looking to do is create that low-cost, highly-accurate, simple-to-use test that would be accessible to a lot of people," Dr. John Banovetz, chief technology officer for 3M, told Cheddar.
The antigen-based test, which looks at proteins on the virus, would offer a "preliminary view" of a patient's coronavirus status — though ideally, patients would follow up with a doctor, he added.
"Our goal would be a point-of-care test, so maybe it's taken in a doctor's office. Maybe you pick it up at the pharmacy," Banovetz said.
The goal is to start producing tests by the end of summer or early fall. Once manufacturing is rolling, 3M could produce millions of tests per day, according to the company.
As cases surge across the country and many anticipate a second wave in states where the infection rate has dropped off, calls for more testing are growing.
More than 41 million tests have been reported to the CDC, with a 9 percent positivity rate, but the U.S. continues to lag behind other countries by some measures.
In the meantime, the Trump administration is relying on the private sector to meet the demand for tests, putting pressure on companies such as 3M to come up with a solution.
"We're going as quick as we can right now," he said. "Our focus is trying to get that accuracy up and in a way that we know that we can mass-produce it. That's really where 3M can help contribute to this, our ability to be able to commercialize and bring to market new ideas and innovations."
Researchers report harmful levels of toxic lead were found in the bones of 46% of bald eagles sampled in 38 states. Similar rates of lead exposure were found in golden eagles, according to their study Thursday in the journal Science.
As more and more states end mask mandates and ease other COVID restrictions, discussions about the endemic phase of the pandemic have been growing. For weeks, scientists have warned about how contagious the omicron variant is, but now it seems the tone has shifted and governors are rolling back policies they've had in place for months. Dr. Eric Feigl-Ding, epidemiologist and senior fellow at the Federation of American Scientists, joined Cheddar's Opening Bell to discuss what the next phase of the pandemic might look like, how to act now that mask mandates are ending, and if we should be worried about another variant emerging.
Swedish electric motorcycle maker Cake says its mission is to inspire society to adopt a zero-emission lifestyle. The company admits this is a lofty goal that covers a lot of ground - so it's starting with the world of urban mobility and last-mile deliveries. The company also has an agreement in place with NorthVolt to continually improve the environmental impact of batteries for electric vehicles. Stefan Ytterborn, Founder & CEO of Cake, joins Cheddar Climate to discuss.
One retailer and publicly-traded company says it is on a mission to inspire a new generation of consumers to think secondhand - first. thredUP is one of the world's largest resale platforms for women's and kids' apparel, shoes, and accessories. The company says it is changing the way consumers shop and ushering in a more sustainable future for the fashion industry. Anthony Marino, President of thredUP, joins Cheddar Climate to discuss.
German vaccine maker BioNTech unveiled plans Wednesday to establish manufacturing facilities in Africa that would boost the availability of much-needed medicines on the continent.
As we celebrate Black History Month, Cheddar is highlighting prominent Black Americans who are carving their own historic paths and trailblazing in their industries. Today we feature Dr. Kizzmekia Corbett.
